What can be considered an appropriate statistical method for the primary...
In this article, we propose a phase I-II design in two stages for the
co...
In parametric Bayesian designs of early phase cancer clinical trials wit...
Delayed separation of survival curves is a common occurrence in confirma...
Phase I-II cancer clinical trial designs are intended to accelerate drug...
Integrated phase I-II clinical trial designs are efficient approaches to...
A common feature of many recent trials evaluating the effects of
immunot...
In confirmatory cancer clinical trials, overall survival (OS) is normall...
Dealing with non-proportional hazards is increasingly common nowadays wh...
The use of drug combinations in clinical trials is increasingly common d...
Proportional hazards are a common assumption when designing confirmatory...